Development of New Technologies Needed for Studying the Human Microbiome (R21)

Archived

National Institutes of Health

Description

Purpose. The purpose of this FOA is to solicit applications to develop new and improved technologies for obtaining samples of individual microbial isolates or strains, from the human microbiota, suitable for complete genomic sequence analysis. The goal is to expand the number of reference microbial genome sequences, which in turn will aid in the analysis of the complex microbial populations resident in and on the human body. Mechanism of Support. This FOA will utilize the NIH Exploratory/Developmental Research Grant (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, RFA-RM-09-008 that solicits applications under the R01 mechanism. Funds Available and Anticipated Number of Awards. $2 million is available in FY10 for this FOA and the parallel R01 FOA in combination. It is anticipated that 2-4 R01 grants and 2-6 R21 grants will be awarded. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Who can apply

  • State governments
  • Public and State controlled institutions of higher education
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedJul 16, 2009
  • ClosesSep 14, 2009
  • Award ceiling$200,000
  • Program funding$2,000,000
  • CFDA93.310
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro